Panic, Perception, and pCO2

  • M. A. van den Hout
Conference paper


Explanations of panic disorder (PD) refer to underlying pathogenic processes that are assumed to be specific to PDs. There are various ways to test the validity of such theories on the dynamics of panic. Particularly important, if not decisive, are tests aimed at triggering and neutralizing the hypothetical underlying process. Triggering the pathogenic mechanism should arouse panic, preferably only in PD, while neutralizing the process should reduce pathology.


Panic Disorder Panic Disorder Panic Attack Lactate Infusion Subjective Anxiety 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Alexander PE, Alexander DD (1985) Alprazolam treatment for panic disorders. J Clin Psychiatry 47: 301–304Google Scholar
  2. Bonn JA, Harrison J, Rees L (1973) Lactate infusion in the treatment of “free-floating” anxiety. Can HJ Psychiatry 18: 41–46Google Scholar
  3. Chambless DL, Caputo GG, Bright P, Gallagher R (1984) Assessment of fear of fear in agoraphobics: the body sensations questionnaire and the agoraphobic cognitions questionnaire. J Consult Clin Psychol 52: 1090–1097PubMedCrossRefGoogle Scholar
  4. Charney DS et al (1984) Noradrenergic function in panic anxiety. Arch Gen Psychiatry 41: 751PubMedGoogle Scholar
  5. Chamey DS, Woods SW, Goodman WK, Rifkin B, Kind MRN, Aiken B, Quadrino MS, Heninger GR (1986) Drug treatment of panic disorder; the comparative efficacy of imipramine, alprazolam and trazodone. J Clin Psychiatry 47: 580–586Google Scholar
  6. Chouinard G, Annable L, Fontaine R, Solyom L (1982) Alprazolam in the treatment of generalized anxiety and panic disorders: a double blind placebo controlled study. Psychopharmacology 77: 229–233PubMedCrossRefGoogle Scholar
  7. Clark DM (1986) A cognitive approach to panic. Behav Res Ther 24: 461–470PubMedCrossRefGoogle Scholar
  8. Ehlers A, Margraf J, Roth WT (1986) Experimental induction of panic attacks. In: Hand J, Wittchen HU (eds) Panic and phobias. Empirical evidence of theoretical models and longterm effects of behavioral treatments. Springer, Berlin Heidelberg New YorkGoogle Scholar
  9. Elam M, Yao T, Thoren T, Svensson TH (1981) Hypercapnia and hyperoxia: chemoreceptor mediated control of locus coereleus neurons and splanchnic sympathetic nerves. Brain Res 222: 373–381PubMedCrossRefGoogle Scholar
  10. Emmelkamp PMG (1982) Phobic and obsessive compulsive disorders: theory, research and practice. Plenum, New YorkGoogle Scholar
  11. Fyer AJ, Liebowitz MR, Gorman JM, Campeas R, Levin A, Davies SO, Goetz D, Klein DF (1987) Discontinuation of Alprazolam treatment in panic patients. Am J Psychiatry 144: 303–308PubMedGoogle Scholar
  12. Garssen B, van Veenendaal W, Bloemink R (1983) Agoraphobia and the hyperventilation syndrome. Behav Res Ther 21: 643–649PubMedCrossRefGoogle Scholar
  13. Garssen B (1986) Psychofysiologie van de adern-haling en het hyperventilatiesyndroom; psychophysiology of respiration and the hyperventilation syndrome (with a summary in English). Doctoral thesis, Utrecht, HollandGoogle Scholar
  14. Gorman JM; Askanazi J, Liebowitz MR, Fyer AJ, Stein J, Kinney JM, Klein DF (1984) Response to hyperventilation in a group of patients with panic disorder. Am J Psychiatry 141: 857–861PubMedGoogle Scholar
  15. Gorman JM, Fyer AJ, Ross DC, Cohen S, Martinez JM, Liebowitz MR, Klein DF (1985) Normalization of veneus pH, pCO2 and bicarbonate levels after blockade of panic attacks. Psychiatry Res 14: 57–65PubMedCrossRefGoogle Scholar
  16. Griez E, Pols H, van den Hout MA (1987) Acid base balance in real life panic. J Affective Disord 12: 263–266CrossRefGoogle Scholar
  17. Hibbert GA (1984) Ideational components of anxiety: their origin and content. Br J Psychiatry 144: 618–624PubMedCrossRefGoogle Scholar
  18. Hibbert GA (1985) Ambulatory monitoring of transcutaneous pCOz. In: Lacey J, Sturgeon J (eds) Proceedings of the 15th European conference on psychosomatic medicine. Libby, LondonGoogle Scholar
  19. Hout MA van den (1987) The explanation of experimental panic. In: Rachman S, Maser JD (eds) Panic: psychological perspectives. Erlbaum, Hillsdale, pp 237–258Google Scholar
  20. Hout MA van den, van der Molen GM, Griez E, Lousberg H (1987a) Specificity of interoceptive fear to panic disorders. J Psychopathol Behav Assess 9: 99–109CrossRefGoogle Scholar
  21. Hout MA van den, van der Molen GM, Griez E, Lousberg H, Jansen A (1987b) Reduction of CO2-induced anxiety in patients with panic attacks after repeated CO2 exposure. Am J Psychiatry 144: 788–791PubMedGoogle Scholar
  22. Hout MA van den, Boek C, van der Molen GM, Jansen A, Griez E (1987c) Rebreathing to cope with hyperventilation. Experimental tests of the paper bag method. J Behav Med (in press)Google Scholar
  23. Ley R (1985) Agoraphobia, the panic attack and the hyperventilation syndrome. Behav Res Ther 23: 79–81PubMedCrossRefGoogle Scholar
  24. Lousberg H, Griez E, van den Hout MA (to be published) Carbon dioxide chemosensitivity in panic disorder. Acta Psychiatr ScandGoogle Scholar
  25. Lydiard RB, Laraia MT, Ballenger JC, Howell EF (1987) Emergence of depressive symptoms in patients receiving alprazolam for panic disorder. Am J Psychiatry 5: 664–665Google Scholar
  26. Margraf J, Ehlers A, Roth WT (1987) Expectancy effects and hyperventilation as laboratory stressors. In: Hellhamer D, Florin I, Weiner H (eds) New frontiers in stress research. Huber, TorontoGoogle Scholar
  27. Molen GM van der, van den Hout MA, Vroemen J, Lousberg H, Griez E (1986) Cognitive determinants of lactate induced anxiety. Behav Res Ther 24: 677–680PubMedCrossRefGoogle Scholar
  28. Monteiro WO, Noshirvani HF, Marks IM, Lelliot PP (1987) Anorganismic from clomipramine in obsessive compulsive disorder. A controlled trial. Br J Psychiatry 151: 107–112PubMedCrossRefGoogle Scholar
  29. Nutt DJ (1986) Increased central alpha2 adrenoceptor sensitivity in panic disorder. Psycho-pharmacology. 90: 268–269Google Scholar
  30. Pearson MG, Peattie B, Quadiri MR, Finn R (1985) Abnormalities of respiratory centre function and pottasium homeostasis in the chronic hyperventilation syndrome. Paper presented at the 5th international symposium on respiratory psychophysiology. Nijmegen, The NetherlandsGoogle Scholar
  31. Pennebaker JW (1982) The psychology of physical Symptoms. Springer, Berlin Heidelberg New YorkCrossRefGoogle Scholar
  32. Rapee R (1987) Psychological treatment of panic attacks: theoretical conceptualization and review of evidence. Clin Psychol Rev 7: 427–438CrossRefGoogle Scholar
  33. Rapee R, Matlich R, Murrell E (1986) Cognitive mediation in the affective component of spontaneous panic attacks. J Behav Ther Exp Psychiatry 17: 245–253PubMedCrossRefGoogle Scholar
  34. Reiss S, Peterson RA, Garsky DM, McNally RJ (1986) Anxiety sensitivity, anxiety frequency and the prediction of fearfulness. Behav Res Ther 24: 1–8PubMedCrossRefGoogle Scholar
  35. Salkovskis PM, Warwich HMC, Clark DM, Wessels DJ (1986) A demonstration of acute hyperventilation during naturally occurring panic attacks. Behav Res Ther 24: 91–94PubMedCrossRefGoogle Scholar
  36. Shear MK (1986) Pathophysiology of panic: a review of pharmacologic provocative tests and naturalistic monitoring data. J Clin Psychiatry [Suppl] 47: 18–26Google Scholar
  37. Woods SW, Charney DS, Loke J, Goodman WK, Redmond DE, Henninger GR (1986) Carbon dioxide sensitivity in panic anxiety. Arch Gen Psychiatry 43: 900–909PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1988

Authors and Affiliations

  • M. A. van den Hout

There are no affiliations available

Personalised recommendations